Jae Hyeon Kim
Samsung Medical Center in Korea · Samsung Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jae Hyeon Kim as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06712615 · Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 DiabetesProGen. Co., Ltd. · active not recruiting · Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus · principal investigator
- N/ANCT04161170 · Digital Integrated Healthcare Platform in Patients With Type 2 DiabetesSamsung Medical Center · unknown · Type 2 Diabetes · principal investigator
- Ph2NCT03667300 · Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal InsufficiencySamsung Medical Center · completed · Type2 Diabetes Mellitus, Albuminuria, Renal Insufficiency · principal investigator
- N/ANCT01382420 · Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal IncidentalomaSamsung Medical Center · unknown · Cushing Syndrome · study director
- N/ANCT01157611 · The Effect of Online Based Mentoring Program on the Blood Glucose and Satisfaction Score in Type 1 Diabetes PatientsSamsung Medical Center · completed · Type 1 Diabetes · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 30 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:20 UTC. The ranking covers the 200 most relevant of 1382 PubMed records, and a shared surname and initials can bring in a namesake. All 1382 on PubMed
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.N Engl J Med · 20171,826 citationsRCR 72.0
- Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.N Engl J Med · 20221,024 citationsRCR 73.8
- Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.Lancet Oncol · 2023433 citationsRCR 38.6
- Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.Gastroenterology · 2019398 citationsRCR 19.7
- 380 citationsRCR 20.4
- 320 citationsRCR 84.1
- COMPASS identifies T-cell subsets correlated with clinical outcomes.Nat Biotechnol · 2015252 citationsRCR 6.6
- Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.Lancet Diabetes Endocrinol · 2020190 citationsRCR 11.3
- HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.J Virol · 2014165 citationsRCR 4.5
- Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis.Aliment Pharmacol Ther · 2019126 citationsRCR 8.2